What does Lamotrigine Extended-Release (Lamictal XR) do in plain English—and how does it work inside your body?
Lamotrigine Extended-Release is an FDA-regulated Anti-epileptic Agent (RxNorm RxCUI 850087). Mechanistically, Lamotrigine Extended-Release exerts selective anti-epileptic agent pharmacodynamic activity across 250 mg/1 Tablet, Film Coated, Extended Release and 50 mg/1 Tablet, Film Coated, Extended Release (oral-route route, manufactured/labeled by Yiling Pharmaceutical, Inc.), coupling targeted tissue distribution with predictable systemic biotransformation (NDC 69117-0048, 70518-4442). [1][2].
When your doctor writes a prescription for Lamotrigine Extended-Release (RxNorm RxCUI 850087, also dispensed under brand names including Lamictal XR), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Lamotrigine Extended-Release exerts selective anti-epileptic agent pharmacodynamic activity across 250 mg/1 Tablet, Film Coated, Extended Release and 50 mg/1 Tablet, Film Coated, Extended Release (oral-route route, manufactured/labeled by Yiling Pharmaceutical, Inc.), coupling targeted tissue distribution with predictable systemic biotransformation (NDC 69117-0048, 70518-4442). [2].
Across real-world patient logs on dotMD (84% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Lamotrigine Extended-Release tablet bottle and confirm with your pharmacist that it matches your prescribed strength (250 mg/1 Tablet, Film Coated, Extended Release, 50 mg/1 Tablet, Film Coated, Extended Release, 100 mg/1 Tablet, Film Coated, Extended Release, 200 mg/1 Tablet, Film Coated, Extended Release, 300 mg/1 Tablet, Film Coated, Extended Release).